Stocks | |||||
The table gives an overview of all stocks, alphabetically sorted. | |||||
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z |
Name | Symbol | Analysis date | Close | +/- % |
3M | MMM | Mar 31, 2025 | 146.86 | +1.39 |
4D Molecular Therapeutics | FDMT | Mar 31, 2025 | 3.23 | -11.02 |
51Talk Online Education Group ADR | COE | Mar 31, 2025 | 20.44 | -2.71 |
5E Advanced Materials | FEAM | Mar 31, 2025 | 3.83 | -6.58 |
60 Degrees Pharmaceuticals | SXTP | Mar 31, 2025 | 1.84 | 0.00 |
7-10 Yr Trsy Bear 3X Direxion | TYO | Mar 31, 2025 | 13.57 | -0.80 |
7-10 Yr Trsy Bull 3X Direxion | TYD | Mar 31, 2025 | 25.37 | +0.91 |
7-10 Yr Trsy Ishares | IEF | Mar 31, 2025 | 95.37 | +0.29 |
89bio | ETNB | Mar 31, 2025 | 7.27 | -10.02 |
8x8 | EGHT | Mar 31, 2025 | 2.00 | +0.50 |
908 Devices | MASS | Mar 31, 2025 | 4.48 | +10.89 |
9F ADR | JFU | Mar 31, 2025 | 1.35 | -4.26 |
A-Mark Precious Metals | AMRK | Mar 31, 2025 | 25.37 | -4.08 |
a.k.a Brands | AKA | Mar 31, 2025 | 13.48 | -5.67 |
A.O Smith | AOS | Mar 31, 2025 | 65.36 | -0.38 |
A10 Networks | ATEN | Mar 31, 2025 | 16.34 | -2.39 |
A2Z Cust2Mate Solutions | AZ | Mar 31, 2025 | 7.06 | -3.42 |
AA Mission Acquisition | AAM | Mar 31, 2025 | 10.43 | +1.46 |
AAA - A Rated Corporate Bond Ishares | QLTA | Mar 31, 2025 | 47.53 | +0.19 |
Aadi Bioscience | AADI | Mar 31, 2025 | 2.05 | 0.00 |
AAON | AAON | Mar 31, 2025 | 78.13 | +0.06 |
AAR | AIR | Mar 31, 2025 | 55.99 | -2.01 |
Aardvark Therapeutics | AARD | Mar 31, 2025 | 7.51 | 0.00 |
Abacus Global Management | ABL | Mar 31, 2025 | 7.49 | -1.71 |
Abbott Laboratories | ABT | Mar 31, 2025 | 132.65 | +1.40 |
AbbVie | ABBV | Mar 31, 2025 | 209.52 | +2.06 |
AbCellera Biologics | ABCL | Mar 31, 2025 | 2.23 | -3.46 |
Abeona Therapeutics | ABEO | Mar 31, 2025 | 4.76 | -4.23 |
Abercrombie & Fitch | ANF | Mar 31, 2025 | 76.37 | -0.26 |
Aberdeen Asia-Pacificome Fund | FAX | Mar 31, 2025 | 15.70 | +0.19 |
|
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.